AiPing Pharmaceutical Inc
FDA Approved Drugs
AiPing Pharmaceutical Inc
FDA Approved Drugs Database
FDA approved drug product records including application numbers, product numbers, drug names, active ingredients, dosage forms, strengths, approval dates and regulatory status.
- Total Records 141
- Latest Approval Date Jun 24, 2026
- Data Source FDA
- First Approval Date Jan 01, 1982
Company Overview
Company
AiPing Pharmaceutical Inc
Country
U.S.A
Website
Social Profiles
Company Snapshot
AiPing Pharmaceutical Inc
350 W Wireless Boulevard\nHauppauge, NY
U.S.A
www.aipingpharmaceutical.com/ solutions@aipingpharma.com View on MapFDA Approved Drug Records ( 141 records )
Drug Name
ALBUTEROL SULFATE AND IPRATROPIUM BROMIDE
Product Number
1
Dosage Form
-
Strength
EQ 0.083% BASE;0.017%
Approval Date
2006-12-21
Active Ingredient
ALBUTEROL SULFATE; IPRATROPIUM BROMIDE
Application Number
76867
Product Number
1
Dosage Form
-
Strength
EQ 0.083% BASE;0.017%
Approval Date
2006-12-21
Regulatory Status
Discontinued
Drug Name
ALLOPURINOL
Product Number
1
Dosage Form
-
Strength
100MG
Approval Date
1985-12-31
Active Ingredient
ALLOPURINOL
Application Number
70268
Product Number
1
Dosage Form
-
Strength
100MG
Approval Date
1985-12-31
Regulatory Status
Discontinued
Drug Name
AMITRIPTYLINE HYDROCHLORIDE
Product Number
1
Dosage Form
-
Strength
25MG
Approval Date
2020-04-07
Active Ingredient
AMITRIPTYLINE HYDROCHLORIDE
Application Number
212654
Product Number
1
Dosage Form
-
Strength
25MG
Approval Date
2020-04-07
Regulatory Status
RX
Drug Name
AMITRIPTYLINE HYDROCHLORIDE
Product Number
2
Dosage Form
-
Strength
10MG
Approval Date
2021-09-29
Active Ingredient
AMITRIPTYLINE HYDROCHLORIDE
Application Number
212654
Product Number
2
Dosage Form
-
Strength
10MG
Approval Date
2021-09-29
Regulatory Status
RX
Drug Name
AMITRIPTYLINE HYDROCHLORIDE
Product Number
3
Dosage Form
-
Strength
50MG
Approval Date
2021-09-29
Active Ingredient
AMITRIPTYLINE HYDROCHLORIDE
Application Number
212654
Product Number
3
Dosage Form
-
Strength
50MG
Approval Date
2021-09-29
Regulatory Status
RX
Drug Name
AMITRIPTYLINE HYDROCHLORIDE
Product Number
4
Dosage Form
-
Strength
75MG
Approval Date
2021-09-29
Active Ingredient
AMITRIPTYLINE HYDROCHLORIDE
Application Number
212654
Product Number
4
Dosage Form
-
Strength
75MG
Approval Date
2021-09-29
Regulatory Status
RX
Drug Name
AMITRIPTYLINE HYDROCHLORIDE
Product Number
5
Dosage Form
-
Strength
100MG
Approval Date
2021-09-29
Active Ingredient
AMITRIPTYLINE HYDROCHLORIDE
Application Number
212654
Product Number
5
Dosage Form
-
Strength
100MG
Approval Date
2021-09-29
Regulatory Status
RX
Drug Name
AMITRIPTYLINE HYDROCHLORIDE
Product Number
6
Dosage Form
-
Strength
150MG
Approval Date
2021-09-29
Active Ingredient
AMITRIPTYLINE HYDROCHLORIDE
Application Number
212654
Product Number
6
Dosage Form
-
Strength
150MG
Approval Date
2021-09-29
Regulatory Status
RX
Drug Name
ARFORMOTEROL TARTRATE
Product Number
1
Dosage Form
-
Strength
EQ 0.015MG BASE/2ML
Approval Date
2024-04-02
Active Ingredient
ARFORMOTEROL TARTRATE
Application Number
214901
Product Number
1
Dosage Form
-
Strength
EQ 0.015MG BASE/2ML
Approval Date
2024-04-02
Regulatory Status
RX
Drug Name
ARIPIPRAZOLE
Product Number
1
Dosage Form
-
Strength
2MG
Approval Date
2017-01-09
Active Ingredient
ARIPIPRAZOLE
Application Number
91279
Product Number
1
Dosage Form
-
Strength
2MG
Approval Date
2017-01-09
Regulatory Status
Discontinued
Drug Name
ARIPIPRAZOLE
Product Number
2
Dosage Form
-
Strength
5MG
Approval Date
2017-01-09
Active Ingredient
ARIPIPRAZOLE
Application Number
91279
Product Number
2
Dosage Form
-
Strength
5MG
Approval Date
2017-01-09
Regulatory Status
Discontinued
Drug Name
ARIPIPRAZOLE
Product Number
3
Dosage Form
-
Strength
10MG
Approval Date
2017-01-09
Active Ingredient
ARIPIPRAZOLE
Application Number
91279
Product Number
3
Dosage Form
-
Strength
10MG
Approval Date
2017-01-09
Regulatory Status
Discontinued
Drug Name
ARIPIPRAZOLE
Product Number
4
Dosage Form
-
Strength
15MG
Approval Date
2017-01-09
Active Ingredient
ARIPIPRAZOLE
Application Number
91279
Product Number
4
Dosage Form
-
Strength
15MG
Approval Date
2017-01-09
Regulatory Status
Discontinued
Drug Name
ARIPIPRAZOLE
Product Number
5
Dosage Form
-
Strength
20MG
Approval Date
2017-01-09
Active Ingredient
ARIPIPRAZOLE
Application Number
91279
Product Number
5
Dosage Form
-
Strength
20MG
Approval Date
2017-01-09
Regulatory Status
Discontinued
Drug Name
ARIPIPRAZOLE
Product Number
6
Dosage Form
-
Strength
30MG
Approval Date
2017-01-09
Active Ingredient
ARIPIPRAZOLE
Application Number
91279
Product Number
6
Dosage Form
-
Strength
30MG
Approval Date
2017-01-09
Regulatory Status
Discontinued
Drug Name
ATENOLOL
Product Number
1
Dosage Form
-
Strength
100MG
Approval Date
1988-07-15
Active Ingredient
ATENOLOL
Application Number
72304
Product Number
1
Dosage Form
-
Strength
100MG
Approval Date
1988-07-15
Regulatory Status
RX
Drug Name
ATENOLOL
Product Number
2
Dosage Form
-
Strength
25MG
Approval Date
1992-07-31
Active Ingredient
ATENOLOL
Application Number
72304
Product Number
2
Dosage Form
-
Strength
25MG
Approval Date
1992-07-31
Regulatory Status
RX
Drug Name
ATENOLOL
Product Number
3
Dosage Form
-
Strength
50MG
Approval Date
1988-07-18
Active Ingredient
ATENOLOL
Application Number
72304
Product Number
3
Dosage Form
-
Strength
50MG
Approval Date
1988-07-18
Regulatory Status
RX
Drug Name
ATENOLOL AND CHLORTHALIDONE
Product Number
1
Dosage Form
-
Strength
100MG;25MG
Approval Date
1990-05-31
Active Ingredient
ATENOLOL; CHLORTHALIDONE
Application Number
72302
Product Number
1
Dosage Form
-
Strength
100MG;25MG
Approval Date
1990-05-31
Regulatory Status
RX
Drug Name
ATENOLOL AND CHLORTHALIDONE
Product Number
2
Dosage Form
-
Strength
50MG;25MG
Approval Date
1990-05-31
Active Ingredient
ATENOLOL; CHLORTHALIDONE
Application Number
72302
Product Number
2
Dosage Form
-
Strength
50MG;25MG
Approval Date
1990-05-31
Regulatory Status
RX
Drug Name
BENZTROPINE MESYLATE
Product Number
1
Dosage Form
-
Strength
0.5MG
Approval Date
1996-12-12
Active Ingredient
BENZTROPINE MESYLATE
Application Number
40103
Product Number
1
Dosage Form
-
Strength
0.5MG
Approval Date
1996-12-12
Regulatory Status
RX
Drug Name
BENZTROPINE MESYLATE
Product Number
2
Dosage Form
-
Strength
1MG
Approval Date
1996-12-12
Active Ingredient
BENZTROPINE MESYLATE
Application Number
40103
Product Number
2
Dosage Form
-
Strength
1MG
Approval Date
1996-12-12
Regulatory Status
RX
Drug Name
BENZTROPINE MESYLATE
Product Number
3
Dosage Form
-
Strength
2MG
Approval Date
1996-12-12
Active Ingredient
BENZTROPINE MESYLATE
Application Number
40103
Product Number
3
Dosage Form
-
Strength
2MG
Approval Date
1996-12-12
Regulatory Status
RX
Drug Name
BUSPIRONE HYDROCHLORIDE
Product Number
1
Dosage Form
-
Strength
5MG
Approval Date
2015-12-16
Active Ingredient
BUSPIRONE HYDROCHLORIDE
Application Number
202087
Product Number
1
Dosage Form
-
Strength
5MG
Approval Date
2015-12-16
Regulatory Status
RX
Drug Name
BUSPIRONE HYDROCHLORIDE
Product Number
2
Dosage Form
-
Strength
10MG
Approval Date
2015-12-16
Active Ingredient
BUSPIRONE HYDROCHLORIDE
Application Number
202087
Product Number
2
Dosage Form
-
Strength
10MG
Approval Date
2015-12-16
Regulatory Status
RX
Drug Name
BUSPIRONE HYDROCHLORIDE
Product Number
3
Dosage Form
-
Strength
15MG
Approval Date
2015-12-16
Active Ingredient
BUSPIRONE HYDROCHLORIDE
Application Number
202087
Product Number
3
Dosage Form
-
Strength
15MG
Approval Date
2015-12-16
Regulatory Status
RX
Drug Name
BUSPIRONE HYDROCHLORIDE
Product Number
4
Dosage Form
-
Strength
30MG
Approval Date
2015-12-16
Active Ingredient
BUSPIRONE HYDROCHLORIDE
Application Number
202087
Product Number
4
Dosage Form
-
Strength
30MG
Approval Date
2015-12-16
Regulatory Status
RX
Drug Name
BUSPIRONE HYDROCHLORIDE
Product Number
5
Dosage Form
-
Strength
7.5MG
Approval Date
2025-07-03
Active Ingredient
BUSPIRONE HYDROCHLORIDE
Application Number
202087
Product Number
5
Dosage Form
-
Strength
7.5MG
Approval Date
2025-07-03
Regulatory Status
RX
Drug Name
CAPTOPRIL
Product Number
1
Dosage Form
-
Strength
12.5MG
Approval Date
2023-01-27
Active Ingredient
CAPTOPRIL
Application Number
214442
Product Number
1
Dosage Form
-
Strength
12.5MG
Approval Date
2023-01-27
Regulatory Status
RX
Drug Name
CAPTOPRIL
Product Number
2
Dosage Form
-
Strength
25MG
Approval Date
2023-01-27
Active Ingredient
CAPTOPRIL
Application Number
214442
Product Number
2
Dosage Form
-
Strength
25MG
Approval Date
2023-01-27
Regulatory Status
RX
Drug Name
CAPTOPRIL
Product Number
3
Dosage Form
-
Strength
50MG
Approval Date
2023-01-27
Active Ingredient
CAPTOPRIL
Application Number
214442
Product Number
3
Dosage Form
-
Strength
50MG
Approval Date
2023-01-27
Regulatory Status
RX
Drug Name
CAPTOPRIL
Product Number
4
Dosage Form
-
Strength
100MG
Approval Date
2023-01-27
Active Ingredient
CAPTOPRIL
Application Number
214442
Product Number
4
Dosage Form
-
Strength
100MG
Approval Date
2023-01-27
Regulatory Status
RX
Drug Name
CETIRIZINE HYDROCHLORIDE ALLERGY
Product Number
2
Dosage Form
-
Strength
5MG
Approval Date
2014-03-11
Active Ingredient
CETIRIZINE HYDROCHLORIDE
Application Number
202277
Product Number
2
Dosage Form
-
Strength
5MG
Approval Date
2014-03-11
Regulatory Status
Discontinued
Drug Name
CETIRIZINE HYDROCHLORIDE ALLERGY
Product Number
4
Dosage Form
-
Strength
10MG
Approval Date
2014-03-11
Active Ingredient
CETIRIZINE HYDROCHLORIDE
Application Number
202277
Product Number
4
Dosage Form
-
Strength
10MG
Approval Date
2014-03-11
Regulatory Status
Discontinued
Drug Name
CETIRIZINE HYDROCHLORIDE HIVES
Product Number
1
Dosage Form
-
Strength
5MG
Approval Date
2014-03-11
Active Ingredient
CETIRIZINE HYDROCHLORIDE
Application Number
202277
Product Number
1
Dosage Form
-
Strength
5MG
Approval Date
2014-03-11
Regulatory Status
Discontinued
Drug Name
CETIRIZINE HYDROCHLORIDE HIVES
Product Number
3
Dosage Form
-
Strength
10MG
Approval Date
2014-03-11
Active Ingredient
CETIRIZINE HYDROCHLORIDE
Application Number
202277
Product Number
3
Dosage Form
-
Strength
10MG
Approval Date
2014-03-11
Regulatory Status
Discontinued
Drug Name
CHLORTHALIDONE
Product Number
1
Dosage Form
-
Strength
50MG
Approval Date
1982-01-01
Active Ingredient
CHLORTHALIDONE
Application Number
87381
Product Number
1
Dosage Form
-
Strength
50MG
Approval Date
1982-01-01
Regulatory Status
Discontinued
Drug Name
CHLORTHALIDONE
Product Number
2
Dosage Form
-
Strength
25MG
Approval Date
1982-01-01
Active Ingredient
CHLORTHALIDONE
Application Number
87381
Product Number
2
Dosage Form
-
Strength
25MG
Approval Date
1982-01-01
Regulatory Status
Discontinued
Drug Name
CHOLESTYRAMINE
Product Number
1
Dosage Form
-
Strength
EQ 4GM RESIN/PACKET
Approval Date
2022-01-21
Active Ingredient
CHOLESTYRAMINE
Application Number
214877
Product Number
1
Dosage Form
-
Strength
EQ 4GM RESIN/PACKET
Approval Date
2022-01-21
Regulatory Status
RX
Drug Name
CHOLESTYRAMINE
Product Number
2
Dosage Form
-
Strength
EQ 4GM RESIN/SCOOPFUL
Approval Date
2022-01-21
Active Ingredient
CHOLESTYRAMINE
Application Number
214877
Product Number
2
Dosage Form
-
Strength
EQ 4GM RESIN/SCOOPFUL
Approval Date
2022-01-21
Regulatory Status
RX
Drug Name
CIPROFLOXACIN HYDROCHLORIDE
Product Number
2
Dosage Form
-
Strength
EQ 250MG BASE
Approval Date
2004-06-09
Active Ingredient
CIPROFLOXACIN HYDROCHLORIDE
Application Number
76593
Product Number
2
Dosage Form
-
Strength
EQ 250MG BASE
Approval Date
2004-06-09
Regulatory Status
RX
Drug Name
CIPROFLOXACIN HYDROCHLORIDE
Product Number
3
Dosage Form
-
Strength
EQ 500MG BASE
Approval Date
2004-06-09
Active Ingredient
CIPROFLOXACIN HYDROCHLORIDE
Application Number
76593
Product Number
3
Dosage Form
-
Strength
EQ 500MG BASE
Approval Date
2004-06-09
Regulatory Status
RX
Drug Name
CIPROFLOXACIN HYDROCHLORIDE
Product Number
4
Dosage Form
-
Strength
EQ 750MG BASE
Approval Date
2004-06-09
Active Ingredient
CIPROFLOXACIN HYDROCHLORIDE
Application Number
76593
Product Number
4
Dosage Form
-
Strength
EQ 750MG BASE
Approval Date
2004-06-09
Regulatory Status
RX
Drug Name
CYCLOBENZAPRINE HYDROCHLORIDE
Product Number
1
Dosage Form
-
Strength
10MG
Approval Date
1991-11-19
Active Ingredient
CYCLOBENZAPRINE HYDROCHLORIDE
Application Number
72854
Product Number
1
Dosage Form
-
Strength
10MG
Approval Date
1991-11-19
Regulatory Status
Discontinued
Drug Name
CYCLOBENZAPRINE HYDROCHLORIDE
Product Number
2
Dosage Form
-
Strength
5MG
Approval Date
2006-02-03
Active Ingredient
CYCLOBENZAPRINE HYDROCHLORIDE
Application Number
72854
Product Number
2
Dosage Form
-
Strength
5MG
Approval Date
2006-02-03
Regulatory Status
Discontinued
Drug Name
CYCLOBENZAPRINE HYDROCHLORIDE
Product Number
3
Dosage Form
-
Strength
7.5MG
Approval Date
2026-05-13
Active Ingredient
CYCLOBENZAPRINE HYDROCHLORIDE
Application Number
72854
Product Number
3
Dosage Form
-
Strength
7.5MG
Approval Date
2026-05-13
Regulatory Status
RX
Drug Name
DONEPEZIL HYDROCHLORIDE
Product Number
1
Dosage Form
-
Strength
5MG
Approval Date
2011-05-31
Active Ingredient
DONEPEZIL HYDROCHLORIDE
Application Number
90290
Product Number
1
Dosage Form
-
Strength
5MG
Approval Date
2011-05-31
Regulatory Status
Discontinued
Drug Name
DONEPEZIL HYDROCHLORIDE
Product Number
2
Dosage Form
-
Strength
10MG
Approval Date
2011-05-31
Active Ingredient
DONEPEZIL HYDROCHLORIDE
Application Number
90290
Product Number
2
Dosage Form
-
Strength
10MG
Approval Date
2011-05-31
Regulatory Status
Discontinued
Drug Name
DONEPEZIL HYDROCHLORIDE
Product Number
1
Dosage Form
-
Strength
5MG
Approval Date
2011-05-10
Active Ingredient
DONEPEZIL HYDROCHLORIDE
Application Number
91198
Product Number
1
Dosage Form
-
Strength
5MG
Approval Date
2011-05-10
Regulatory Status
Discontinued
Drug Name
DONEPEZIL HYDROCHLORIDE
Product Number
2
Dosage Form
-
Strength
10MG
Approval Date
2011-05-10
Active Ingredient
DONEPEZIL HYDROCHLORIDE
Application Number
91198
Product Number
2
Dosage Form
-
Strength
10MG
Approval Date
2011-05-10
Regulatory Status
Discontinued
Drug Name
DOXEPIN HYDROCHLORIDE
Product Number
1
Dosage Form
-
Strength
EQ 10MG BASE
Approval Date
2020-07-28
Active Ingredient
DOXEPIN HYDROCHLORIDE
Application Number
213474
Product Number
1
Dosage Form
-
Strength
EQ 10MG BASE
Approval Date
2020-07-28
Regulatory Status
RX
Drug Name
DOXEPIN HYDROCHLORIDE
Product Number
2
Dosage Form
-
Strength
EQ 25MG BASE
Approval Date
2020-07-28
Active Ingredient
DOXEPIN HYDROCHLORIDE
Application Number
213474
Product Number
2
Dosage Form
-
Strength
EQ 25MG BASE
Approval Date
2020-07-28
Regulatory Status
RX
Drug Name
DOXEPIN HYDROCHLORIDE
Product Number
3
Dosage Form
-
Strength
EQ 50MG BASE
Approval Date
2020-07-28
Active Ingredient
DOXEPIN HYDROCHLORIDE
Application Number
213474
Product Number
3
Dosage Form
-
Strength
EQ 50MG BASE
Approval Date
2020-07-28
Regulatory Status
RX
Drug Name
DOXEPIN HYDROCHLORIDE
Product Number
4
Dosage Form
-
Strength
EQ 75MG BASE
Approval Date
2020-07-28
Active Ingredient
DOXEPIN HYDROCHLORIDE
Application Number
213474
Product Number
4
Dosage Form
-
Strength
EQ 75MG BASE
Approval Date
2020-07-28
Regulatory Status
RX
Drug Name
DOXEPIN HYDROCHLORIDE
Product Number
5
Dosage Form
-
Strength
EQ 100MG BASE
Approval Date
2020-07-28
Active Ingredient
DOXEPIN HYDROCHLORIDE
Application Number
213474
Product Number
5
Dosage Form
-
Strength
EQ 100MG BASE
Approval Date
2020-07-28
Regulatory Status
RX
Drug Name
DOXYCYCLINE
Product Number
1
Dosage Form
-
Strength
40MG
Approval Date
2025-10-01
Active Ingredient
DOXYCYCLINE
Application Number
219978
Product Number
1
Dosage Form
-
Strength
40MG
Approval Date
2025-10-01
Regulatory Status
RX
Drug Name
ENALAPRIL MALEATE
Product Number
1
Dosage Form
-
Strength
5MG
Approval Date
2001-03-23
Active Ingredient
ENALAPRIL MALEATE
Application Number
75178
Product Number
1
Dosage Form
-
Strength
5MG
Approval Date
2001-03-23
Regulatory Status
RX
Drug Name
ENALAPRIL MALEATE
Product Number
2
Dosage Form
-
Strength
2.5MG
Approval Date
2001-03-23
Active Ingredient
ENALAPRIL MALEATE
Application Number
75178
Product Number
2
Dosage Form
-
Strength
2.5MG
Approval Date
2001-03-23
Regulatory Status
RX
Drug Name
ENALAPRIL MALEATE
Product Number
3
Dosage Form
-
Strength
10MG
Approval Date
2001-03-23
Active Ingredient
ENALAPRIL MALEATE
Application Number
75178
Product Number
3
Dosage Form
-
Strength
10MG
Approval Date
2001-03-23
Regulatory Status
RX
Drug Name
ENALAPRIL MALEATE
Product Number
4
Dosage Form
-
Strength
20MG
Approval Date
2001-03-23
Active Ingredient
ENALAPRIL MALEATE
Application Number
75178
Product Number
4
Dosage Form
-
Strength
20MG
Approval Date
2001-03-23
Regulatory Status
RX
Drug Name
ESCITALOPRAM OXALATE
Product Number
1
Dosage Form
-
Strength
EQ 5MG BASE
Approval Date
2012-09-12
Active Ingredient
ESCITALOPRAM OXALATE
Application Number
77512
Product Number
1
Dosage Form
-
Strength
EQ 5MG BASE
Approval Date
2012-09-12
Regulatory Status
Discontinued
Drug Name
ESCITALOPRAM OXALATE
Product Number
2
Dosage Form
-
Strength
EQ 10MG BASE
Approval Date
2012-09-12
Active Ingredient
ESCITALOPRAM OXALATE
Application Number
77512
Product Number
2
Dosage Form
-
Strength
EQ 10MG BASE
Approval Date
2012-09-12
Regulatory Status
Discontinued
Drug Name
ESCITALOPRAM OXALATE
Product Number
3
Dosage Form
-
Strength
EQ 20MG BASE
Approval Date
2012-09-12
Active Ingredient
ESCITALOPRAM OXALATE
Application Number
77512
Product Number
3
Dosage Form
-
Strength
EQ 20MG BASE
Approval Date
2012-09-12
Regulatory Status
Discontinued
Drug Name
FLUVOXAMINE MALEATE
Product Number
1
Dosage Form
-
Strength
25MG
Approval Date
2000-11-29
Active Ingredient
FLUVOXAMINE MALEATE
Application Number
75888
Product Number
1
Dosage Form
-
Strength
25MG
Approval Date
2000-11-29
Regulatory Status
RX
Drug Name
FLUVOXAMINE MALEATE
Product Number
2
Dosage Form
-
Strength
50MG
Approval Date
2000-11-29
Active Ingredient
FLUVOXAMINE MALEATE
Application Number
75888
Product Number
2
Dosage Form
-
Strength
50MG
Approval Date
2000-11-29
Regulatory Status
RX
Drug Name
FLUVOXAMINE MALEATE
Product Number
3
Dosage Form
-
Strength
100MG
Approval Date
2000-11-29
Active Ingredient
FLUVOXAMINE MALEATE
Application Number
75888
Product Number
3
Dosage Form
-
Strength
100MG
Approval Date
2000-11-29
Regulatory Status
RX
Drug Name
FOLIC ACID
Product Number
1
Dosage Form
-
Strength
1MG
Approval Date
2013-07-12
Active Ingredient
FOLIC ACID
Application Number
91145
Product Number
1
Dosage Form
-
Strength
1MG
Approval Date
2013-07-12
Regulatory Status
RX
Drug Name
GLIPIZIDE
Product Number
1
Dosage Form
-
Strength
5MG
Approval Date
1995-04-07
Active Ingredient
GLIPIZIDE
Application Number
74305
Product Number
1
Dosage Form
-
Strength
5MG
Approval Date
1995-04-07
Regulatory Status
RX
Drug Name
GLIPIZIDE
Product Number
2
Dosage Form
-
Strength
10MG
Approval Date
1995-04-07
Active Ingredient
GLIPIZIDE
Application Number
74305
Product Number
2
Dosage Form
-
Strength
10MG
Approval Date
1995-04-07
Regulatory Status
RX
Drug Name
GUANFACINE HYDROCHLORIDE
Product Number
1
Dosage Form
-
Strength
EQ 1MG BASE
Approval Date
2022-06-08
Active Ingredient
GUANFACINE HYDROCHLORIDE
Application Number
216399
Product Number
1
Dosage Form
-
Strength
EQ 1MG BASE
Approval Date
2022-06-08
Regulatory Status
RX
Drug Name
GUANFACINE HYDROCHLORIDE
Product Number
2
Dosage Form
-
Strength
EQ 2MG BASE
Approval Date
2022-06-08
Active Ingredient
GUANFACINE HYDROCHLORIDE
Application Number
216399
Product Number
2
Dosage Form
-
Strength
EQ 2MG BASE
Approval Date
2022-06-08
Regulatory Status
RX
Drug Name
HALOPERIDOL
Product Number
1
Dosage Form
-
Strength
0.5MG
Approval Date
1987-02-17
Active Ingredient
HALOPERIDOL
Application Number
71128
Product Number
1
Dosage Form
-
Strength
0.5MG
Approval Date
1987-02-17
Regulatory Status
Discontinued
Drug Name
HALOPERIDOL
Product Number
1
Dosage Form
-
Strength
1MG
Approval Date
1987-02-17
Active Ingredient
HALOPERIDOL
Application Number
71129
Product Number
1
Dosage Form
-
Strength
1MG
Approval Date
1987-02-17
Regulatory Status
Discontinued
Drug Name
HALOPERIDOL
Product Number
1
Dosage Form
-
Strength
2MG
Approval Date
1987-02-17
Active Ingredient
HALOPERIDOL
Application Number
71130
Product Number
1
Dosage Form
-
Strength
2MG
Approval Date
1987-02-17
Regulatory Status
RX
Drug Name
HALOPERIDOL
Product Number
2
Dosage Form
-
Strength
5MG
Approval Date
1987-02-17
Active Ingredient
HALOPERIDOL
Application Number
71130
Product Number
2
Dosage Form
-
Strength
5MG
Approval Date
1987-02-17
Regulatory Status
RX
Drug Name
HALOPERIDOL
Product Number
3
Dosage Form
-
Strength
10MG
Approval Date
1987-05-12
Active Ingredient
HALOPERIDOL
Application Number
71130
Product Number
3
Dosage Form
-
Strength
10MG
Approval Date
1987-05-12
Regulatory Status
RX
Drug Name
HALOPERIDOL
Product Number
4
Dosage Form
-
Strength
0.5MG
Approval Date
2026-04-08
Active Ingredient
HALOPERIDOL
Application Number
71130
Product Number
4
Dosage Form
-
Strength
0.5MG
Approval Date
2026-04-08
Regulatory Status
RX
Drug Name
HALOPERIDOL
Product Number
5
Dosage Form
-
Strength
1MG
Approval Date
2026-04-08
Active Ingredient
HALOPERIDOL
Application Number
71130
Product Number
5
Dosage Form
-
Strength
1MG
Approval Date
2026-04-08
Regulatory Status
RX
Drug Name
HALOPERIDOL
Product Number
6
Dosage Form
-
Strength
20MG
Approval Date
2026-04-08
Active Ingredient
HALOPERIDOL
Application Number
71130
Product Number
6
Dosage Form
-
Strength
20MG
Approval Date
2026-04-08
Regulatory Status
RX
Drug Name
HALOPERIDOL
Product Number
1
Dosage Form
-
Strength
20MG
Approval Date
1987-05-12
Active Ingredient
HALOPERIDOL
Application Number
71133
Product Number
1
Dosage Form
-
Strength
20MG
Approval Date
1987-05-12
Regulatory Status
Discontinued
Drug Name
LABETALOL HYDROCHLORIDE
Product Number
1
Dosage Form
-
Strength
100MG
Approval Date
1998-08-04
Active Ingredient
LABETALOL HYDROCHLORIDE
Application Number
75113
Product Number
1
Dosage Form
-
Strength
100MG
Approval Date
1998-08-04
Regulatory Status
RX
Drug Name
LABETALOL HYDROCHLORIDE
Product Number
2
Dosage Form
-
Strength
200MG
Approval Date
1998-08-04
Active Ingredient
LABETALOL HYDROCHLORIDE
Application Number
75113
Product Number
2
Dosage Form
-
Strength
200MG
Approval Date
1998-08-04
Regulatory Status
RX
Drug Name
LABETALOL HYDROCHLORIDE
Product Number
3
Dosage Form
-
Strength
300MG
Approval Date
1998-08-04
Active Ingredient
LABETALOL HYDROCHLORIDE
Application Number
75113
Product Number
3
Dosage Form
-
Strength
300MG
Approval Date
1998-08-04
Regulatory Status
RX
Drug Name
LAMOTRIGINE
Product Number
1
Dosage Form
-
Strength
25MG
Approval Date
2009-01-27
Active Ingredient
LAMOTRIGINE
Application Number
78645
Product Number
1
Dosage Form
-
Strength
25MG
Approval Date
2009-01-27
Regulatory Status
Discontinued
Drug Name
LAMOTRIGINE
Product Number
2
Dosage Form
-
Strength
100MG
Approval Date
2009-01-27
Active Ingredient
LAMOTRIGINE
Application Number
78645
Product Number
2
Dosage Form
-
Strength
100MG
Approval Date
2009-01-27
Regulatory Status
Discontinued
Drug Name
LAMOTRIGINE
Product Number
3
Dosage Form
-
Strength
150MG
Approval Date
2009-01-27
Active Ingredient
LAMOTRIGINE
Application Number
78645
Product Number
3
Dosage Form
-
Strength
150MG
Approval Date
2009-01-27
Regulatory Status
Discontinued
Drug Name
LAMOTRIGINE
Product Number
4
Dosage Form
-
Strength
200MG
Approval Date
2009-01-27
Active Ingredient
LAMOTRIGINE
Application Number
78645
Product Number
4
Dosage Form
-
Strength
200MG
Approval Date
2009-01-27
Regulatory Status
Discontinued
Drug Name
LEVETIRACETAM
Product Number
1
Dosage Form
-
Strength
500MG
Approval Date
2016-08-26
Active Ingredient
LEVETIRACETAM
Application Number
204754
Product Number
1
Dosage Form
-
Strength
500MG
Approval Date
2016-08-26
Regulatory Status
RX
Drug Name
LEVETIRACETAM
Product Number
2
Dosage Form
-
Strength
750MG
Approval Date
2016-08-26
Active Ingredient
LEVETIRACETAM
Application Number
204754
Product Number
2
Dosage Form
-
Strength
750MG
Approval Date
2016-08-26
Regulatory Status
RX
Drug Name
LISINOPRIL AND HYDROCHLOROTHIAZIDE
Product Number
1
Dosage Form
-
Strength
12.5MG;10MG
Approval Date
2002-07-01
Active Ingredient
HYDROCHLOROTHIAZIDE; LISINOPRIL
Application Number
76262
Product Number
1
Dosage Form
-
Strength
12.5MG;10MG
Approval Date
2002-07-01
Regulatory Status
RX
Drug Name
LISINOPRIL AND HYDROCHLOROTHIAZIDE
Product Number
2
Dosage Form
-
Strength
12.5MG;20MG
Approval Date
2002-07-01
Active Ingredient
HYDROCHLOROTHIAZIDE; LISINOPRIL
Application Number
76262
Product Number
2
Dosage Form
-
Strength
12.5MG;20MG
Approval Date
2002-07-01
Regulatory Status
RX
Drug Name
LISINOPRIL AND HYDROCHLOROTHIAZIDE
Product Number
3
Dosage Form
-
Strength
25MG;20MG
Approval Date
2002-07-01
Active Ingredient
HYDROCHLOROTHIAZIDE; LISINOPRIL
Application Number
76262
Product Number
3
Dosage Form
-
Strength
25MG;20MG
Approval Date
2002-07-01
Regulatory Status
RX
Drug Name
LOSARTAN POTASSIUM
Product Number
1
Dosage Form
-
Strength
25MG
Approval Date
2010-10-06
Active Ingredient
LOSARTAN POTASSIUM
Application Number
90544
Product Number
1
Dosage Form
-
Strength
25MG
Approval Date
2010-10-06
Regulatory Status
RX
Drug Name
LOSARTAN POTASSIUM
Product Number
2
Dosage Form
-
Strength
50MG
Approval Date
2010-10-06
Active Ingredient
LOSARTAN POTASSIUM
Application Number
90544
Product Number
2
Dosage Form
-
Strength
50MG
Approval Date
2010-10-06
Regulatory Status
RX
Drug Name
LOSARTAN POTASSIUM
Product Number
3
Dosage Form
-
Strength
100MG
Approval Date
2010-10-06
Active Ingredient
LOSARTAN POTASSIUM
Application Number
90544
Product Number
3
Dosage Form
-
Strength
100MG
Approval Date
2010-10-06
Regulatory Status
RX
Drug Name
MELOXICAM
Product Number
1
Dosage Form
-
Strength
7.5MG
Approval Date
2006-07-19
Active Ingredient
MELOXICAM
Application Number
77920
Product Number
1
Dosage Form
-
Strength
7.5MG
Approval Date
2006-07-19
Regulatory Status
RX
Drug Name
MELOXICAM
Product Number
2
Dosage Form
-
Strength
15MG
Approval Date
2006-07-19
Active Ingredient
MELOXICAM
Application Number
77920
Product Number
2
Dosage Form
-
Strength
15MG
Approval Date
2006-07-19
Regulatory Status
RX
Drug Name
METHIMAZOLE
Product Number
1
Dosage Form
-
Strength
5MG
Approval Date
2005-02-18
Active Ingredient
METHIMAZOLE
Application Number
40547
Product Number
1
Dosage Form
-
Strength
5MG
Approval Date
2005-02-18
Regulatory Status
RX
Drug Name
METHIMAZOLE
Product Number
2
Dosage Form
-
Strength
10MG
Approval Date
2005-02-18
Active Ingredient
METHIMAZOLE
Application Number
40547
Product Number
2
Dosage Form
-
Strength
10MG
Approval Date
2005-02-18
Regulatory Status
RX
Drug Name
METHIMAZOLE
Product Number
4
Dosage Form
-
Strength
20MG
Approval Date
2005-02-18
Active Ingredient
METHIMAZOLE
Application Number
40547
Product Number
4
Dosage Form
-
Strength
20MG
Approval Date
2005-02-18
Regulatory Status
Discontinued
Drug Name
METHOCARBAMOL
Product Number
1
Dosage Form
-
Strength
750MG
Approval Date
1982-01-01
Active Ingredient
METHOCARBAMOL
Application Number
84615
Product Number
1
Dosage Form
-
Strength
750MG
Approval Date
1982-01-01
Regulatory Status
Discontinued
Drug Name
METHOCARBAMOL
Product Number
1
Dosage Form
-
Strength
500MG
Approval Date
1982-01-01
Active Ingredient
METHOCARBAMOL
Application Number
84616
Product Number
1
Dosage Form
-
Strength
500MG
Approval Date
1982-01-01
Regulatory Status
Discontinued
Drug Name
METOCLOPRAMIDE HYDROCHLORIDE
Product Number
1
Dosage Form
-
Strength
EQ 10MG BASE
Approval Date
1990-01-30
Active Ingredient
METOCLOPRAMIDE HYDROCHLORIDE
Application Number
72215
Product Number
1
Dosage Form
-
Strength
EQ 10MG BASE
Approval Date
1990-01-30
Regulatory Status
RX
Drug Name
METOCLOPRAMIDE HYDROCHLORIDE
Product Number
2
Dosage Form
-
Strength
EQ 5MG BASE
Approval Date
2024-11-05
Active Ingredient
METOCLOPRAMIDE HYDROCHLORIDE
Application Number
72215
Product Number
2
Dosage Form
-
Strength
EQ 5MG BASE
Approval Date
2024-11-05
Regulatory Status
RX
Drug Name
MONTELUKAST SODIUM
Product Number
1
Dosage Form
-
Strength
EQ 4MG BASE
Approval Date
2012-08-03
Active Ingredient
MONTELUKAST SODIUM
Application Number
91414
Product Number
1
Dosage Form
-
Strength
EQ 4MG BASE
Approval Date
2012-08-03
Regulatory Status
Discontinued
Drug Name
MONTELUKAST SODIUM
Product Number
2
Dosage Form
-
Strength
EQ 5MG BASE
Approval Date
2012-08-03
Active Ingredient
MONTELUKAST SODIUM
Application Number
91414
Product Number
2
Dosage Form
-
Strength
EQ 5MG BASE
Approval Date
2012-08-03
Regulatory Status
Discontinued
Drug Name
OXYBUTYNIN CHLORIDE
Product Number
1
Dosage Form
-
Strength
5MG
Approval Date
1996-07-31
Active Ingredient
OXYBUTYNIN CHLORIDE
Application Number
74625
Product Number
1
Dosage Form
-
Strength
5MG
Approval Date
1996-07-31
Regulatory Status
RX
Drug Name
PIOGLITAZONE HYDROCHLORIDE
Product Number
1
Dosage Form
-
Strength
EQ 15MG BASE
Approval Date
2013-02-13
Active Ingredient
PIOGLITAZONE HYDROCHLORIDE
Application Number
78670
Product Number
1
Dosage Form
-
Strength
EQ 15MG BASE
Approval Date
2013-02-13
Regulatory Status
RX
Drug Name
PIOGLITAZONE HYDROCHLORIDE
Product Number
2
Dosage Form
-
Strength
EQ 30MG BASE
Approval Date
2013-02-13
Active Ingredient
PIOGLITAZONE HYDROCHLORIDE
Application Number
78670
Product Number
2
Dosage Form
-
Strength
EQ 30MG BASE
Approval Date
2013-02-13
Regulatory Status
RX
Drug Name
PIOGLITAZONE HYDROCHLORIDE
Product Number
3
Dosage Form
-
Strength
EQ 45MG BASE
Approval Date
2013-02-13
Active Ingredient
PIOGLITAZONE HYDROCHLORIDE
Application Number
78670
Product Number
3
Dosage Form
-
Strength
EQ 45MG BASE
Approval Date
2013-02-13
Regulatory Status
RX
Drug Name
PREDNISONE
Product Number
2
Dosage Form
-
Strength
5MG
Approval Date
1982-01-01
Active Ingredient
PREDNISONE
Application Number
80336
Product Number
2
Dosage Form
-
Strength
5MG
Approval Date
1982-01-01
Regulatory Status
Discontinued
Drug Name
PREGABALIN
Product Number
1
Dosage Form
-
Strength
330MG
Approval Date
2025-01-28
Active Ingredient
PREGABALIN
Application Number
217857
Product Number
1
Dosage Form
-
Strength
330MG
Approval Date
2025-01-28
Regulatory Status
RX
Drug Name
PREGABALIN
Product Number
2
Dosage Form
-
Strength
165MG
Approval Date
2026-06-24
Active Ingredient
PREGABALIN
Application Number
217857
Product Number
2
Dosage Form
-
Strength
165MG
Approval Date
2026-06-24
Regulatory Status
RX
Drug Name
PREVALITE
Product Number
1
Dosage Form
-
Strength
EQ 4GM RESIN/PACKET
Approval Date
1996-02-22
Active Ingredient
CHOLESTYRAMINE
Application Number
73263
Product Number
1
Dosage Form
-
Strength
EQ 4GM RESIN/PACKET
Approval Date
1996-02-22
Regulatory Status
RX
Drug Name
PREVALITE
Product Number
2
Dosage Form
-
Strength
EQ 4GM RESIN/SCOOPFUL
Approval Date
1997-10-30
Active Ingredient
CHOLESTYRAMINE
Application Number
73263
Product Number
2
Dosage Form
-
Strength
EQ 4GM RESIN/SCOOPFUL
Approval Date
1997-10-30
Regulatory Status
RX
Drug Name
PROPRANOLOL HYDROCHLORIDE
Product Number
1
Dosage Form
-
Strength
90MG
Approval Date
1986-10-22
Active Ingredient
PROPRANOLOL HYDROCHLORIDE
Application Number
71288
Product Number
1
Dosage Form
-
Strength
90MG
Approval Date
1986-10-22
Regulatory Status
Discontinued
Drug Name
RIVAROXABAN
Product Number
1
Dosage Form
-
Strength
10MG
Approval Date
2025-05-14
Active Ingredient
RIVAROXABAN
Application Number
216995
Product Number
1
Dosage Form
-
Strength
10MG
Approval Date
2025-05-14
Regulatory Status
RX
Drug Name
RIVAROXABAN
Product Number
2
Dosage Form
-
Strength
15MG
Approval Date
2025-05-14
Active Ingredient
RIVAROXABAN
Application Number
216995
Product Number
2
Dosage Form
-
Strength
15MG
Approval Date
2025-05-14
Regulatory Status
RX
Drug Name
RIVAROXABAN
Product Number
3
Dosage Form
-
Strength
20MG
Approval Date
2025-05-14
Active Ingredient
RIVAROXABAN
Application Number
216995
Product Number
3
Dosage Form
-
Strength
20MG
Approval Date
2025-05-14
Regulatory Status
RX
Drug Name
SORINE
Product Number
1
Dosage Form
-
Strength
80MG
Approval Date
2001-04-27
Active Ingredient
SOTALOL HYDROCHLORIDE
Application Number
75500
Product Number
1
Dosage Form
-
Strength
80MG
Approval Date
2001-04-27
Regulatory Status
RX
Drug Name
SORINE
Product Number
2
Dosage Form
-
Strength
160MG
Approval Date
2001-04-27
Active Ingredient
SOTALOL HYDROCHLORIDE
Application Number
75500
Product Number
2
Dosage Form
-
Strength
160MG
Approval Date
2001-04-27
Regulatory Status
RX
Drug Name
SORINE
Product Number
3
Dosage Form
-
Strength
240MG
Approval Date
2001-04-27
Active Ingredient
SOTALOL HYDROCHLORIDE
Application Number
75500
Product Number
3
Dosage Form
-
Strength
240MG
Approval Date
2001-04-27
Regulatory Status
RX
Drug Name
SORINE
Product Number
4
Dosage Form
-
Strength
120MG
Approval Date
2001-04-27
Active Ingredient
SOTALOL HYDROCHLORIDE
Application Number
75500
Product Number
4
Dosage Form
-
Strength
120MG
Approval Date
2001-04-27
Regulatory Status
RX
Drug Name
SULFAMETHOXAZOLE AND TRIMETHOPRIM
Product Number
1
Dosage Form
-
Strength
800MG;160MG
Approval Date
1986-11-13
Active Ingredient
SULFAMETHOXAZOLE; TRIMETHOPRIM
Application Number
70890
Product Number
1
Dosage Form
-
Strength
800MG;160MG
Approval Date
1986-11-13
Regulatory Status
Discontinued
Drug Name
SULFAMETHOXAZOLE AND TRIMETHOPRIM
Product Number
2
Dosage Form
-
Strength
400MG;80MG
Approval Date
1986-11-13
Active Ingredient
SULFAMETHOXAZOLE; TRIMETHOPRIM
Application Number
70890
Product Number
2
Dosage Form
-
Strength
400MG;80MG
Approval Date
1986-11-13
Regulatory Status
Discontinued
Drug Name
TOPIRAMATE
Product Number
1
Dosage Form
-
Strength
25MG
Approval Date
2010-01-07
Active Ingredient
TOPIRAMATE
Application Number
78499
Product Number
1
Dosage Form
-
Strength
25MG
Approval Date
2010-01-07
Regulatory Status
Discontinued
Drug Name
TOPIRAMATE
Product Number
2
Dosage Form
-
Strength
50MG
Approval Date
2010-01-07
Active Ingredient
TOPIRAMATE
Application Number
78499
Product Number
2
Dosage Form
-
Strength
50MG
Approval Date
2010-01-07
Regulatory Status
Discontinued
Drug Name
TOPIRAMATE
Product Number
3
Dosage Form
-
Strength
100MG
Approval Date
2010-01-07
Active Ingredient
TOPIRAMATE
Application Number
78499
Product Number
3
Dosage Form
-
Strength
100MG
Approval Date
2010-01-07
Regulatory Status
Discontinued
Drug Name
TOPIRAMATE
Product Number
4
Dosage Form
-
Strength
200MG
Approval Date
2010-01-07
Active Ingredient
TOPIRAMATE
Application Number
78499
Product Number
4
Dosage Form
-
Strength
200MG
Approval Date
2010-01-07
Regulatory Status
Discontinued
Drug Name
TRAZODONE HYDROCHLORIDE
Product Number
1
Dosage Form
-
Strength
100MG
Approval Date
1990-04-30
Active Ingredient
TRAZODONE HYDROCHLORIDE
Application Number
72483
Product Number
1
Dosage Form
-
Strength
100MG
Approval Date
1990-04-30
Regulatory Status
Discontinued
Drug Name
VALACYCLOVIR HYDROCHLORIDE
Product Number
1
Dosage Form
-
Strength
EQ 500MG BASE
Approval Date
2010-05-24
Active Ingredient
VALACYCLOVIR HYDROCHLORIDE
Application Number
77478
Product Number
1
Dosage Form
-
Strength
EQ 500MG BASE
Approval Date
2010-05-24
Regulatory Status
Discontinued
Drug Name
VALACYCLOVIR HYDROCHLORIDE
Product Number
2
Dosage Form
-
Strength
EQ 1GM BASE
Approval Date
2010-05-24
Active Ingredient
VALACYCLOVIR HYDROCHLORIDE
Application Number
77478
Product Number
2
Dosage Form
-
Strength
EQ 1GM BASE
Approval Date
2010-05-24
Regulatory Status
Discontinued
Drug Name
WARFARIN SODIUM
Product Number
1
Dosage Form
-
Strength
1MG
Approval Date
2013-06-27
Active Ingredient
WARFARIN SODIUM
Application Number
200104
Product Number
1
Dosage Form
-
Strength
1MG
Approval Date
2013-06-27
Regulatory Status
Discontinued
Drug Name
WARFARIN SODIUM
Product Number
2
Dosage Form
-
Strength
2MG
Approval Date
2013-06-27
Active Ingredient
WARFARIN SODIUM
Application Number
200104
Product Number
2
Dosage Form
-
Strength
2MG
Approval Date
2013-06-27
Regulatory Status
Discontinued
Drug Name
WARFARIN SODIUM
Product Number
3
Dosage Form
-
Strength
2.5MG
Approval Date
2013-06-27
Active Ingredient
WARFARIN SODIUM
Application Number
200104
Product Number
3
Dosage Form
-
Strength
2.5MG
Approval Date
2013-06-27
Regulatory Status
Discontinued
Drug Name
WARFARIN SODIUM
Product Number
4
Dosage Form
-
Strength
3MG
Approval Date
2013-06-27
Active Ingredient
WARFARIN SODIUM
Application Number
200104
Product Number
4
Dosage Form
-
Strength
3MG
Approval Date
2013-06-27
Regulatory Status
Discontinued
Drug Name
WARFARIN SODIUM
Product Number
5
Dosage Form
-
Strength
4MG
Approval Date
2013-06-27
Active Ingredient
WARFARIN SODIUM
Application Number
200104
Product Number
5
Dosage Form
-
Strength
4MG
Approval Date
2013-06-27
Regulatory Status
Discontinued
Drug Name
WARFARIN SODIUM
Product Number
6
Dosage Form
-
Strength
5MG
Approval Date
2013-06-27
Active Ingredient
WARFARIN SODIUM
Application Number
200104
Product Number
6
Dosage Form
-
Strength
5MG
Approval Date
2013-06-27
Regulatory Status
Discontinued
Drug Name
WARFARIN SODIUM
Product Number
7
Dosage Form
-
Strength
6MG
Approval Date
2013-06-27
Active Ingredient
WARFARIN SODIUM
Application Number
200104
Product Number
7
Dosage Form
-
Strength
6MG
Approval Date
2013-06-27
Regulatory Status
Discontinued
Drug Name
WARFARIN SODIUM
Product Number
8
Dosage Form
-
Strength
7.5MG
Approval Date
2013-06-27
Active Ingredient
WARFARIN SODIUM
Application Number
200104
Product Number
8
Dosage Form
-
Strength
7.5MG
Approval Date
2013-06-27
Regulatory Status
Discontinued
Drug Name
WARFARIN SODIUM
Product Number
9
Dosage Form
-
Strength
10MG
Approval Date
2013-06-27
Active Ingredient
WARFARIN SODIUM
Application Number
200104
Product Number
9
Dosage Form
-
Strength
10MG
Approval Date
2013-06-27
Regulatory Status
Discontinued
Related Databases
-
FDA Inspections
0 View
-
EDQM CEP
0 View
-
KDMF
0 View
-
Japan DMF
0 View
-
Eudra GMP
0 View
-
NDC Database
0 View
-
FDA Approved Drugs Database
141 View
-
Drug Prices in Switzerland
0 View
Drug Status Breakdown
141 total- Discontinued
- RX
Official Source
FDA approved drug data is based on publicly available U.S. Food and Drug Administration Orange Book information.
Visit FDA Orange BookFDA Approved Drug Record Details Preview
Explore important FDA approved drug information available in the records above.
Drug Name
ALBUTEROL SULFATE AND IPRATROPIUM BROMIDE
Application Number
76867
Product Number
1
Active Ingredient
ALBUTEROL SULFATE; IPRATROPIUM BROMIDE
Dosage Form
-
Strength
EQ 0.083% BASE;0.017%
FDA Approved Drug Data
Approved drug product information
Regular Updates
Data maintained from official sources
Structured Database
Searchable pharmaceutical data
Reliable Data
Organized FDA drug records
Create a New Buying Request
Fields marked with * are mandatory.